Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TWLXC
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SBT-6290
|
|||||
| Synonyms |
SBT6290; SBT 6290
Click to Show/Hide
|
|||||
| Organization |
Silverback Therapeutics, Inc.; ARS Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Terminated in phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Terminated in phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Nectin-4 (NECTIN4)
|
Antigen Info | ||||
| Payload Name |
TLR8 agonist
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.